ACE Inhibitors Lower Pneumonia Threat

Published Online: Friday, April 1, 2005

Patients who have had a stroke can ward off the risk of pneumonia with angiotensin-converting enzyme (ACE) inhibitors. For the study, the researchers evaluated the risk of pneumonia in >1000 patients who had had a stroke. The patients involved in the 35-month study were given 1 of 3 treatments: ACE inhibitors, other blood pressure drugs, or a placebo. The data showed 2.8% of the ACE inhibitor group developed pneumonia, compared with 8.5% of the patients in the other 2 groups. (The findings were reported in Neurology, February 9, 2005.)

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues